New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 28, 2014
08:03 EDTABAXAbaxis receives CLIA waiver for cpillary sampling for cholesterol, HDL
Abaxis announced the Food and Drug Administration granted CLIA waived status for capillary draw for CHOL, HDL and TRIG. Combined with existing CLIA waived tests for liver diagnostics using capillary samples, Abaxis now has two complete Lipid Panels which can be used by healthcare professionals to diagnose, treat and monitor hyperlipidemia patients using a sample obtained from either venous blood or a capillary draw. Obtaining CLIA waived status for capillary sampling is an important step in bringing comprehensive care closer to the patients in the U.S.
News For ABAX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for ABAX

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use